Updated on July 27th, 2021 by Bob Ciura
DRIP stands for Dividend Reinvestment Plan. When an investor is enrolled in a DRIP, it means that incoming dividend payments are used to purchase more shares of the issuing company – automatically.
Many businesses offer DRIPs that require the investors to pay fees. Obviously, paying fees is a negative for investors. As a general rule, investors are better off avoiding DRIPs that charge fees.
Fortunately, many companies offer no-fee DRIPs. These allow investors to use their hard-earned dividends to build even larger positions in their favorite high-quality, dividend-paying companies – for free.
Dividend Aristocrats are the perfect complement to DRIPs. Dividend Aristocrats are elite companies that satisfy the following:
- Are in the S&P 500 Index
- Have 25+ consecutive years of dividend increases
- Meet certain minimum size & liquidity requirements
You can download an Excel spreadsheet with the full list of all 65 Dividend Aristocrats (with additional financial metrics such as price-to-earnings ratios and dividend yields) by clicking the link below:
Think about the powerful combination of DRIPs and Dividend Aristocrats…
You are reinvesting dividends into a company that pays higher dividends every year. This means that every year you get more shares – and each share is paying you more dividend income than the previous year.
This makes a powerful (and cost-effective) compounding machine.
This article takes a look at the top 15 Dividend Aristocrats that offer no-fee DRIPs, ranked in order of expected total returns from lowest to highest.
The updated list for 2021 includes our top 15 Dividend Aristocrats, ranked by expected returns according to the Sure Analysis Research Database, that offer no-fee DRIPs to shareholders. You can skip to analysis of any individual Dividend Aristocrat below:
- #15: A.O. Smith (AOS)
- #14: Federal Realty Investment Trust (FRT)
- #13: Sherwin-Williams (SHW)
- #12: Abbott Laboratories (ABT)
- #11: Emerson Electric (EMR)
- #10: Illinois Tool Works (ITW)
- #9: Hormel Foods (HRL)
- #8: S&P Global Inc. (SPGI)
- #7: Chubb Limited (CB)
- #6: Realty Income (O)
- #5: 3M Company (MMM)
- #4: Aflac Incorporated
- #3: Exxon Mobil (XOM)
- #2: Johnson & Johnson (JNJ)
- #1: AbbVie Inc. (ABBV)
Additionally, please see the video below for more coverage.
No-Fee DRIP Dividend Aristocrat #15: A.O. Smith (AOS)
A.O. Smith is a leading manufacturer of residential and commercial water heaters, boilers and water treatment products. A.O. Smith generates the majority of its sales in North America, with the remainder from the rest of the world. It has category-leading brands across its various geographic markets.
The company is perhaps best-known for its water heaters. It operates in two operating segments, separated by geography:
Source: Investor Presentation
As you can see, the company has a sizable international presence.
A.O. Smith has raised its dividend for 26 years in a row, including an 8.3% increase in October 2020. Its long history of dividend growth is the result of a leadership position in its industry and a high historical growth rate.
A.O. Smith reported its first quarter earnings results on April 29. Revenue of $770 million increased 21% year-over-year, including 4% growth in North America. Earnings–per–share of $0.60 was up by a very large 88% on a year over year basis.
A.O. Smith has also updated its guidance for 2021, the company is now forecasting earnings–per–share in a range of $2.55 and $2.65, which would reflect a meaningful earnings acceleration versus 2020. If A.O. Smith hits the midpoint of its guidance range, the company’s profits will also be on par with pre–COVID records set in 2018.
A.O. Smith operates in a growing industry, with a particularly attractive long-term growth catalyst in the emerging markets. The trade war and the coronavirus have dented emerging market growth in recent quarters, but should not impact A.O. Smith’s long-term growth.
The long-term growth potential in the emerging markets remains very favorable for water purification and heating products. The company is poised to keep growing for years in China thanks to the country’s huge population, its robust GDP growth, and a booming middle class. India will also be a major growth market, for the same reasons.
Over the long-term, we believe that A.O. Smith can grow its EPS by 6% per year. With a 1.5% dividend yield and annual dividend increases, A.O. Smith is an appealing stock for dividend growth investors. However, we believe the stock is overvalued right now, and we expect -0.8% annual returns through 2026. Therefore, we rate AOS a sell on valuation concerns.
No-Fee DRIP Dividend Aristocrat #14: Federal Realty Investment Trust (FRT)
Federal Realty was founded in 1962. As a Real Estate Investment Trust, Federal Realty’s business model is to own and rent out real estate properties. It uses a significant portion of its rental income, as well as external financing, to acquire new properties. This helps create a “snow-ball” effect of rising income over time.
Federal Realty primarily owns shopping centers. However, it also operates in redevelopment of multi-purpose properties including retail, apartments, and condominiums. The portfolio is highly diversified in terms of tenant base. Federal Realty has a high-quality tenant portfolio.
Source: Investor Presentation
The trust’s investment strategy is to pursue densely-populated, affluent communities, with high demand for commercial and residential real estate. This strategy has fueled strong growth over the past several years.
2020 was a very difficult year for Federal Realty, and the entire REIT group, as the coronavirus pandemic caused store closures across the country. These impacts have lingered through 2021. In the first quarter, FRT reported FFO-per-share of $1.17, a decline of 22% from the same quarter last year. Revenue declined approximately 6% for the quarter.
Despite the declines, there were some positive signs. During the first quarter FRT signed leases for 506,307 square feet of comparable space at an average rent of $36.58 per square foot. Meanwhile, as of April 27th FRT collected ~90% of total Q1 billed recurring rents and ended the quarter with $780 million of cash on hand. The company also reported 2021 FFO per diluted share guidance range of $4.54–$4.70.
However, shares appear significantly overvalued, with a 2021 P/FFO ratio of 26, compared with our fair value estimate of 15. Even with the 3.6% dividend yield and 8% expected FFO-per-share growth per year, we expect negative total returns of -0.8% per year.
We expect total returns of 5.2% per year, mostly comprised of the 4.6% dividend yield. Modest FFO-per-share growth will nearly be offset by an expected decline in the P/FFO multiple.
No-Fee DRIP Dividend Aristocrat #13: Sherwin-Williams (SHW)
Sherwin-Williams, founded in 1866 and headquartered in Cleveland, OH, is North America’s largest manufacturer of paints and coatings. The company distributes its products through wholesalers as well as retail stores (including a chain of more than 4,900 company-operated stores and facilities) to 120 countries under the Sherwin-Williams name.
The company also manufactures Dutch Boy, Pratt & Lambert, Minwax, Thompson’s Waterseal, Krylon, Valspar (acquired in 2017), and other brands.
Source: Investor Presentation
Even with the coronavirus pandemic severely impacting the economy, 2020 was another year of growth for Sherwin-Williams. For the year, Sherwin-Williams generated $18.36 billion in 2020 sales, representing a 2.6% increase compared to 2019. Adjusted earnings-per-share equaled $24.58 for 2020, a 16.4% increase compared to 2019.
Growth has continued in 2021. In the first quarter Sherwin-Williams generated revenue of $4.66 billion, a 12.3% increase compared to Q1 2020. This result was driven by an 8.6% increase in the Americas Group, a 25.0% increase in the Consumer Brands Group and a 12.9% increase in the Performance Coatings Group. Adjusted earnings-per-share equaled $2.06 compared to $1.36 in the year ago quarter. Sherwin-Williams also updated its 2021 guidance, anticipating $8.80 to $9.07 in adjusted earnings-per-share
We believe that Sherwin-Williams is capable of delivering 8% annualized earnings growth over full economic cycles. Growth can come from several factors, including revenue expansion through higher sales at the company’s existing stores, as well as margin improvement, and share repurchases. The company has reduced its share count by roughly -20% throughout the last decade.
Sherwin-Williams is not necessarily in a high-growth industry, but its entrenched position offers the company its fair share of competitive advantages; allowing the business to grow consistently. Further, acquisitions are a way for Sherwin-Williams to enhance its presence, with the recent Valspar transaction being a good example.
The stock trades for more than 30 times earnings. We believe shares are significantly overvalued today. The combination of valuation changes, EPS growth, and the 0.8% dividend yield result in expected annual returns of 1.3% per year.
No-Fee DRIP Dividend Aristocrat #12: Abbott Laboratories (ABT)
Abbott Laboratories is one of the largest medical appliances & equipment manufacturers in the world, comprised of four segments: Nutrition, Diagnostics, Established Pharmaceuticals and Medical Devices. Abbott has increased its dividend for 49 years, including its impressive recent 25% dividend increase. Abbott has a large and diversified product portfolio, with leadership across multiple categories.
On July 22nd, 2021, Abbott Laboratories reported Q2 2021 results for the period ending June 30th, 2021. For the quarter the company generated $10.22 billion in sales (65% outside of the U.S.) representing a 39.5% increase compared to Q2 2020.
Results were up across the board with Diagnostics, Medical Devices, Nutrition and Established Pharmaceuticals increasing organic revenue by 57%, 45%, 9.5% and 14.5% respectively. Diagnostics sales continue to be propelled by demand for COVID-19 tests.
Reported earnings per share equaled $0.66, with adjusted EPS totaling $1.17 versus $0.57 prior. Abbott Laboratories also updated its 2021 guidance, now anticipating adjusted earnings per share of $4.30 to $4.50, down from “at least $5.00” previously.
With a P/E of 27, Abbott appears overvalued. Our fair value estimate is a P/E of 20. Overvaluation could significantly weigh on shareholder returns going forward. Expected EPS growth of 6% per year plus the 1.5% dividend yield will offset the impact of a declining P/E multiple, but total returns are expected at just 1.5% per year over the next five years.
No-Fee DRIP Dividend Aristocrat #11: Emerson Electric (EMR)
Emerson Electric is an ideal candidate for a no-fee DRIP program, as the company has increased its dividend for over 60 years in a row. Emerson Electric was founded in Missouri in 1890. Today, Its global customer base affords it $18+ billion in annual revenue.
Emerson is organized into two major reporting segments called Automation Solutions and Commercial & Residential Solutions. Automation Solutions helps manufacturers minimize energy usage, waste, and other costs in their processes. The Commercial & Residential Solutions segment makes products that protect food quality and safety, as well as boost efficiency in the production process.
2020 was a difficult year because of the coronavirus pandemic and the ensuing impact on the global economy. And yet, Emerson remained highly profitable, which allowed it to continue increasing its dividend.
The company recently concluded its fiscal 2021 second quarter.
Source: Investor Presentation
In the most recent quarter, results came in ahead of expectations on the top and bottom lines. Total sales were up 6% and organic sales were up 2%, which excludes favorable currency of 3% and an impact of acquisitions of 1%. Revenue beat the company’s guidance, with strength seen across its segments. Americas improved against Q1 but was down –4% against last year’s comparable quarter. Europe was up 7%, while AMEA was up 12%, which was driven by a massive 45% year–over–year recovery in China. Adjusted EPS increased 9% year-over-year.
Emerson’s valuation has increased significantly due to its impressive stock price rally over the past year. It is now trading well above our estimate of fair value. The stock trades for ~25 times the midpoint of fiscal 2021 expected EPS, which compares to our estimate of fair value at 19 times earnings.
A declining P/E multiple to the fair value estimate could reduce annual returns. We also expect annual EPS growth of 5%, and Emerson stock has a 2.1% dividend yield. Overall, we expect total returns of 1.7% per year through 2026.
No-Fee DRIP Dividend Aristocrat #10: Illinois Tool Works (ITW)
Illinois Tool Works is a diversified multi-industrial manufacturer with seven unique operating segments: Automotive, Food Equipment, Test & Measurement, Welding, Polymers & Fluids, Construction Products and Specialty Products.
In the 2021 first quarter, ITW reported 10% year-over-year revenue growth. Earnings-per-share of $2.11 rose 19% from the same quarter a year ago. The company also updated its full-year guidance, now expecting 12%-14% earnings-per-share growth for the full year.
Source: Investor Presentation
Illinois Tool Works’ industry is not glamorous or one with outstanding growth rates, but the company has established itself as a major player that continues to grow profitably. Its experienced management and strong fundamentals, such as an above–average return on capital, function as competitive advantages.
Shares trade for a P/E of nearly 30, above our fair value P/E estimate of 19. Expected EPS growth of 7% per year and the 1.5% dividend yield will offset the impact of overvaluation, leading to expected returns of 2% per year over the next five years.
No-Fee DRIP Dividend Aristocrat #9: Hormel Foods (HRL)
Hormel Foods was founded back in 1891 in Minnesota. Since that time, the company has grown into a juggernaut in the food products industry with nearly $10 billion in annual revenue. Hormel has kept with its core competency as a processor of meat products for well over a hundred years, but has also grown into other business lines through acquisitions.
Hormel has a large portfolio of category-leading brands. Just a few of its top brands include include Skippy, SPAM, Applegate, Justin’s, and more than 30 others.
Source: Investor Presentation
Hormel reported second fiscal quarter earnings on May 20th, 2021, with results coming in ahead of expectations on both the top and bottom lines. Total revenue was $2.6 billion, which was up nearly 8% from the year–ago period. Volume was down –3% to 1.2 billion pounds, but better pricing helped drive the top line higher. Q2’s revenue number was a record.
The Refrigerated Foods business saw volume rise 3%, and total sales soar 17%, while segment profit was up 32%. The segment saw a massive recovery in the foodservice business, as well as growth in retail and deli brands.
Hormel’s main competitive advantage is its 30+ products that are either #1 or #2 in their category. Hormel has brands that are proven, and that leadership position is difficult for competitors to supplant. In addition, Hormel has a global network of distributors that few food companies can rival. Hormel’s earnings-per-share actually grew during the Great Recession, a testament to the stock’s defensive nature.
Hormel stock appears overvalued, trading for 25 times this year’s EPS estimate. We expect 5% annual EPS growth, while the stock has a 2.1% dividend yield. Overall, we expect annual returns of 3.3% per year through 2026.
No-Fee DRIP Dividend Aristocrat #8: S&P Global Inc. (SPGI)
S&P Global is a worldwide provider of financial services and business information with revenue of nearly $8 billion. It generates about half of its operating income from its ratings segment, 30% from market and commodities intelligence and the balance from S&P Dow Jones Indices. S&P Global’s revenue is split roughly 55/45 between US and International, respectively.
S&P Global has paid dividends since 1937 and has increased its payout for 48 years. In 2020, revenue was up 11% to $7.44 billion. Adjusted net income was up 20% to $2.83 billion for 2021, and on a per-share basis, adjusted earnings rose 23% to $11.69.
The company also performed well to start 2021. First-quarter revenue increased 13% with growth across all four major business units. Adjusted diluted earnings-per-share increased 24% for the first quarter.
S&P Global has generated strong growth in the past several years.
Source: Investor Presentation
S&P Global’s business has benefited from a series of favorable secular trends. Since the Great Recession in 2009, total corporate debt has been on a steady rise, which means more ratings are needed. Lower global interest rates have continued to lead to more and more issuances of debt. In addition, the company has three other very strong segments that aren’t as dependent upon rates remaining low, should they rise again in the future.
Investors are also becoming increasingly sophisticated and thus demand more real-time data and analytics. Moreover, there is an accelerating demand for index-related investments, such as ETFs.
We expect 7% annual EPS growth over the next five years. The stock has a low dividend yield of 0.8%, but raises its dividend at a high rate. We estimate total return potential at 3.4% per year over the next five years.
No-Fee DRIP Dividend Aristocrat #7: Chubb Limited (CB)
Chubb Ltd is a global provider of insurance and reinsurance services headquartered in Zurich, Switzerland. The company provides insurance services including property & casualty insurance, accident & health insurance, life insurance, and reinsurance. The current version of Chubb was created in 2016, when Ace Limited acquired the ‘old’ Chubb and adopted its name.
Chubb has a large and diversified product portfolio.
Source: Investor Presentation
Chubb’s diversified product line served the company well in 2020, as it was able to remain highly profitable and even produce some growth. For 2020, Chubb reported core operating income of $7.31 per share.
In the 2021 first quarter, revenue of $8.2 billion increased 6% year-over-year. Net written premiums rose 10% in the core P&C segment. Net investment income of $860 million was on par with the same quarter a year ago, as was book value of $131.40.
Chubb has compounded its book value per share at more than 7% per year since 2009. Looking ahead, we believe that a 5% growth rate in per–share book value is feasible for Chubb.
Shares trade for a price-to-book ratio of 1.2, which is above our fair value estimate of 1.05. Meanwhile, expected book-value-per-share growth of 5% and the 1.9% dividend yield lead to total expected returns of 4.2% per year through 2026.
No-Fee DRIP Dividend Aristocrat #6: Realty Income (O)
Realty Income is a retail-focused REIT that owns more than 6,500 properties. It owns retail properties that are not part of a wider retail development (such as a mall), but instead are standalone properties. This means that the properties are viable for many different tenants, including government services, healthcare services, and entertainment. Realty Income is a large-cap stock with a market capitalization above $25 billion.
The company’s long history of dividend payments and increases is due to its high-quality business model and diversified property portfolio.
Source: Investor Presentation
In the most recent quarter, Realty Income beat analyst estimates on both revenue and FFO-per-share. Revenue increased 6.8% from the same quarter last year, due to property acquisitions and rent increases. Adjusted FFO-per-share declined 2.2% due to a higher share count.
Future growth remains likely, as the company’s acquisition pipeline is robust. Last quarter, Realty Income invested $1.03 billion in properties and properties under development or expansion, including $403 million in U.K. properties.
The stock trades for a P/FFO ratio of 20.5, based on our estimate of $3.47 for 2021 FFO-per-share. Our fair value estimate is a P/FFO ratio of 18, which means the stock appears to be overvalued. Offsetting the valuation headwind will be expected FFO-per-share growth of 4.0% and the current dividend yield of 4% leading to total expected returns of about 5% per year.
No-Fee DRIP Dividend Aristocrat #5: 3M Company (MMM)
3M is a diversified global industrial manufacturer. It manufactures ~60,000 products, which are sold in 200 countries around the world. 3M came to dominate the industrial manufacturing industry through a sharp focus on the most attractive market segments.
3M has increased its dividend for over 60 consecutive years. It is on the exclusive list of Dividend Kings, a group of stocks with 50+ consecutive years of dividend growth. You can see all 32 Dividend Kings here.
After a significant downturn in 2020 due to the coronavirus pandemic, 3M has seen a strong recovery to start 2021. You can see an overview of 3M’s second-quarter results in the image below:
Source: Investor Presentation
It has invested heavily across its core areas of focus to build a product portfolio that leads the pack. 3M is composed of four separate divisions. The Safety & Industrial division produces tapes, abrasives, adhesives and supply chain management software, as well as personal protective gear and security products. The Healthcare segment supplies medical and surgical products, as well as drug delivery systems.
Transportation & Electronics division produces fibers and circuits with a goal of using renewable energy sources while reducing costs. The Consumer division sells office supplies, home improvement products, protective materials and stationary supplies.
3M is overvalued right row, with a P/E ratio of 21, compared with our fair value P/E of 19. Negative returns from a declining P/E ratio will be offset by 5% annual EPS growth and the 2.9% dividend yield. Overall, we expect annual returns of 5.3% per year for 3M over the next five years.
No-Fee DRIP Dividend Aristocrat #4: Aflac Inc. (AFL)
Aflac was formed in 1955, when three brothers — John, Paul, and Bill Amos — came up with the idea to sell insurance products that paid cash if a policyholder got sick or injured. In the mid-20th century, workplace injuries were common, with no insurance product at the time to cover this risk.
Related: Detailed analysis on the best insurance stocks.
Today, Aflac has a wide range of product offerings, some of which include accident, short-term disability, critical illness, hospital indemnity, dental, vision, and life insurance.
Source: Investor Presentation
The company specializes in supplemental insurance, which pays out to policy holders if they are sick or injured, and cannot work. Aflac operates in the U.S. and Japan, with Japan accounting for approximately 70% of the company’s revenue. Because of this, investors are exposed to currency risk.
Aflac has increased its dividend for 39 years in a row.
Aflac’s strategy is to increase premium growth through new customers, as well as increase sales to existing customers. It is also investing to expand its distribution channels, including its digital footprint, in the U.S. and Japan.
In the 2021 first quarter, revenue of $5.9 billion increased 13.5% year-over-year, while adjusted earnings-per-share grew 26% year-over-year.
In general terms, Aflac has two sources of income: income from premiums and income from investments. Taking the items collectively, in addition to an active share repurchase program, reasonable expectations would be for 4% annual earnings-per-share growth over the next five years.
However, we believe the stock is slightly overvalued right now, which will reduce shareholder returns. In addition, the current dividend yield of 2.5%, leads to total expected returns of 5.3% per year.
No-Fee DRIP Dividend Aristocrat #3: Exxon Mobil (XOM)
Exxon Mobil is an integrated super-major, with operations across the oil and gas industry. It derives the majority of its earnings from its upstream segment, with the remainder from its downstream (mostly refining) segment and its chemicals segment.
The company reported better-than-expected results for the 2021 first quarter. Exxon Mobil reported a positive net income of $2.7 billion, equaling $0.64 per share for the quarter. This reversed a loss from the same quarter last year, of $610 million.
Exxon Mobil’s growth potential is challenged by the recent decline in commodity prices, as well as the prospect of a global recession due to the coronavirus. We view the coronavirus as a short-term issue which should abate in a matter of months. The company announced it will reduce capital expenditures by $10 billion to preserve cash in this difficult environment.
Thanks to its promising growth projects, Exxon expects to grow its production from about 4.0 to 5.0 million barrels per day by 2025. The Permian will be a major growth driver, as the oil giant has about 10 billion barrels of oil equivalent in the area and expects to reach production of more than 1.0 million barrels per day in the area by 2025.
Guyana will be another major growth driver of Exxon. The company has nearly tripled its estimated reserves in the area, from 3.2 billion barrels in early 2018 to nearly 9.0 billion barrels now.
Including the 6.0% dividend yield, we expect total annual returns of 6.6% per year over the next five years. Exxon Mobil is a riskier Dividend Aristocrat due to its volatile industry.
No-Fee DRIP Dividend Aristocrat #2: Johnson & Johnson (JNJ)
Johnson & Johnson is a global healthcare giant. It has a market capitalization above $400 billion, and generates annual revenue of more than $81 billion. Today, J&J manufactures and sells health care products through three main segments:
- Pharmaceuticals
- Medical Devices
- Consumer Health Products
It has a diversified business model, with strong brands across its three core operating segments. A breakdown of each segment’s performance in the second quarter can be seen in the image below:
Source: Investor Presentation
On 7/21/2021, Johnson & Johnson released second quarter earnings results for the period ending 6/30/2021. Revenue increased 27.1% to $23.3 billion, which was $770 million above what analysts had anticipated. Adjusted earnings–per–share of $2.48 was an $0.81, or 49%, improvement from the prior year and $0.19 better than expected. Pharmaceutical sales remain strong, with revenue growing 17.2% year–over–year.
Johnson & Johnson also provided updated guidance for the year. The company now expects to earn $9.50 to $9.60 per share in 2021, up from $9.42 to $9.57 previously. At the midpoint, this would be a 19% increase from 2020.
J&J has increased its dividend for 58 consecutive years, making it a Dividend King. The stock yields 2.5% right now. In addition, we expect approximately 6% annual earnings-per-share growth over the next five years.Lastly, the stock has a P/E of 18, slightly above our fair value P/E estimate of 17. All together, we expect total returns of 7.1% per year for J&J stock.
No-Fee DRIP Dividend Aristocrat #1: AbbVie Inc. (ABBV)
AbbVie Inc. is a pharmaceutical company spun off by Abbott Laboratories (ABT) in 2013. Its most important product is Humira, which is now facing biosimilar competition in Europe, which has had a noticeable impact on the company. Humira will lose patent protection in the U.S. in 2023. Even so, AbbVie remains a giant in the healthcare sector, with a large and diversified product portfolio.
Source: Investor Presentation
In the 2021 first quarter, revenue of $13 billion increased 51% year-over-year. Revenues were positively impacted by growth from some of its major products, including Skyrizi and Rinvoq, but even more so by the acquisition of Allergan.
Earnings-per-share of $2.95 increased 22% year-over-year. Guidance for 2021 calls for EPS of $12.37 to $12.57 for the full year.
AbbVie’s major risk is loss of exclusivity for Humira. Fortunately, the company’s massive research and development platform is a competitive advantage. Research and development expense totaled $6.5 billion in 2020. AbbVie has multiple growth opportunities to replace Humira, particularly in the therapeutic areas of immunology, hematology, and neuroscience.
Based on expected 2021 earnings-per-share of $12.47, AbbVie trades for a price-to-earnings ratio of ~9.5. Our fair value estimate for AbbVie is a price-to-earnings ratio (P/E) of 10. An expanding P/E multiple could boost shareholder returns over the next five years. In addition, we expect annual earnings growth of 3.0%, while the stock has a 4.4% dividend yield. We expect total annual returns of 8.3% per year over the next five years.
Final Thoughts and Additional Resources
Enrolling in DRIPs can be a great way to compound your portfolio income over time. That being said, I prefer to selectively reinvest my dividends into my current best investment idea. This ensures that DRIPs don’t automatically purchase stocks that I view as overvalued.
Additional resources are listed below for investors interested in further research for DRIP plans.
For dividend growth investors interested in DRIPs, the 15 companies mentioned in this article are a great place to start. Each business is very shareholder friendly, as evidenced by their long dividend histories and their willingness to offer investors no-fee DRIP plans.